Wu Capital
Wu Capital is a provider of investment management services for healthcare and commercial sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Wu Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Wu Capital is a provider of investment management services for healthcare and commercial sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2014 | XiaoHongChun | Angel Round | - |
| 6/2019 | Loving Care | Series B | - |
| 9/2017 | Yunding Technology | Series C | - |
| 7/2018 | Newtop100.com | Series A | 5.9M |
| 6/2018 | Kangaroo Mama | Series A | 3M |
| 9/2021 | RiVAI | Series A | - |
| 11/2019 | Medbanks | Series D | 142M |
| 6/2019 | Laiye | Series B | 35M |
| 2/2020 | Laiye | Series C | 42M |
| 10/2017 | Horizon Robotics | Series A | 0 |
| 8/2021 | Ranok Therapeutics | Series B | 40M |
| 9/2020 | Korro Bio | Series A | 0 |
| 3/2018 | Youyang | Series A | 9.5M |
| 5/2014 | Qianding | Series A | 30M |
| 11/2017 | Semma Therapeutics | Series B | 0 |
| 11/2020 | Inipharm | Series A | 0 |
| 6/2016 | Horizon Robotics | Series A | - |
| 5/2021 | Feiliu | Series A | 31.4M |
| 7/2017 | Liulishuo | Series C | 100M |
| 5/2019 | Sanjieke | Series B | 18.8M |
| 12/2014 | Apricot Forest | Series C | 8.9M |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 6/2019 | Deptrum | Series A | 0 |
| 10/2018 | Cobo | Series A | 13M |
| 1/2016 | Cui Yutao Health Management Center | Series B | 10M |
| 4/2021 | Laiye | Series C | 0 |
| 7/2018 | Meng Fan Japanese | Series A | - |
| 1/2019 | Smart Bees | Series B | 3M |
| 12/2017 | Laiye | Series B | - |
| 5/2023 | Ray Therapeutics | Series A | 0 |
| 12/2020 | Medbanks | Series E | 0 |
| 5/2018 | Roadstar.ai | Series A | 128M |
| 1/2017 | Ivy Baby | Series C | 20M |
| 1/2020 | PACT Pharma | Series C | 0 |
| 1/2022 | Korro Bio | Series B | 0 |
| 3/2020 | Akouos | Series B | 105M |
| 7/2020 | Citrine Medicine | Series A | 0 |
| 3/2019 | Cassia Networks | Series B | 10M |
| 3/2017 | Namihe | Series B | 2.9M |
| 1/2022 | Korro Bio | Series B | 0 |
| 9/2021 | RiVAI | Series A | - |
| 8/2021 | Ranok Therapeutics | Series B | 0 |
| 5/2021 | Feiliu | Series A | 0 |
| 4/2021 | Laiye | Series C | 0 |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 12/2020 | Medbanks | Series E | 0 |
| 11/2020 | Inipharm | Series A | 0 |
| 9/2020 | Korro Bio | Series A | 0 |
| 7/2020 | Citrine Medicine | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
